Rocuronium bromide hameln 10 mg/ml injekčný/infúzny roztok Slovacia - slovacă - ŠÚKL (Štátny ústav pre kontrolu liečiv)

rocuronium bromide hameln 10 mg/ml injekčný/infúzny roztok

hameln pharma gmbh, nemecko - rokuróniumbromid - 63 - myorelaxantia

Rocuronium bromide Kalceks 10 mg/ml injekčný/infúzny roztok Slovacia - slovacă - ŠÚKL (Štátny ústav pre kontrolu liečiv)

rocuronium bromide kalceks 10 mg/ml injekčný/infúzny roztok

as kalceks, lotyšsko - rokuróniumbromid - 63 - myorelaxantia

Rocuronium Fresenius Kabi 10 mg/ml Slovacia - slovacă - ŠÚKL (Štátny ústav pre kontrolu liečiv)

rocuronium fresenius kabi 10 mg/ml

fresenius kabi s.r.o., Česká republika - rokuróniumbromid - 63 - myorelaxantia

Rocuronium B.Braun 10 mg/ml Slovacia - slovacă - ŠÚKL (Štátny ústav pre kontrolu liečiv)

rocuronium b.braun 10 mg/ml

b.braun melsungen ag, nemecko - rokuróniumbromid - 63 - myorelaxantia

Sugammadex Mylan Uniunea Europeană - slovacă - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Fresenius Kabi Uniunea Europeană - slovacă - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Adroiq Uniunea Europeană - slovacă - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Bridion Uniunea Europeană - slovacă - EMA (European Medicines Agency)

bridion

merck sharp & dohme b.v. - sugammadex - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - zvrat neuromuskulárnej blokády indukovanej rokurónom alebo vekuróniom. pre peadiatric počet obyvateľov: sugammadex je iba doporučené na bežné storno rocuronium vyvolaných blokáda u detí a dospievajúcich.

Sugammadex Amomed Uniunea Europeană - slovacă - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulárna blokáda - všetky ostatné terapeutické produkty - zvrat neuromuskulárnej blokády indukovanej rokurónom alebo vekuróniom. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Piramal Uniunea Europeană - slovacă - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuskulárna blokáda - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.